Lorin A Thompson, Iii

Title: Lorin A Thompson, III: Innovator in Central Nervous System Treatments

Introduction

Lorin A Thompson, III is a notable inventor based in Higganum, Connecticut. He has made significant contributions to the field of pharmacology, particularly in the development of compounds aimed at treating disorders of the central nervous system. With a total of 15 patents to his name, Thompson's work has garnered attention in the scientific community.

Latest Patents

Thompson's latest patents include innovative compounds that act as selective NR2B antagonists. These compounds, described by their formula I, include their salts and are designed for various applications. They serve as ligands for the NR2B receptor, which may be beneficial in treating a range of central nervous system disorders. The implications of these discoveries could lead to advancements in therapeutic options for patients suffering from such conditions.

Career Highlights

Thompson is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there focuses on the development of novel therapeutic agents that target critical pathways in the brain. His extensive research and innovative approach have positioned him as a key figure in the field.

Collaborations

Thompson has collaborated with esteemed colleagues, including John E Macor and Jianliang Shi. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.

Conclusion

Lorin A Thompson, III is a prominent inventor whose work in the field of central nervous system treatments has the potential to make a significant impact. His innovative patents and collaborations reflect his dedication to advancing medical science.